Position Paper: The Time Has Come To Change the “Opt-In” Provision of the EU MDR (Article 17)
The “Opt-In” Provision of the EU MDR (Article 17): Undermines EU Law and the Single Market Deprives Hospitals of Sustainable Medical Device Options, and Exacerbates Shortages in the Healthcare Supply Chain The time has come
New AMDR Member Survey Finds Hospitals and Surgical Centers Saved over $465MM (€426MM), Avoided over 98MM Pounds (44.5MM Kg) of Greenhouse Gas Emissions by Using Regulated, Reprocessed Single-Use Medical Devices from AMDR Members in 2023
[Washington, DC / Berlin Germany – 16 October 2024] A record 11,967 hospitals and surgical centers saved nearly half a billion dollars and eliminated greenhouse gas emissions equivalent to 7.5 Olympic swimming pools filled with
AMDR Statement: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™
23 September 2024 Statement from AMDR: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™ In September 2020, a Medtronic-funded study purporting to show soiled reprocessed LigaSure devices was published in the Journal